 He joined aTyr Pharma as executive chairman and later became CEO.aTyr was founded by Paul Schimmel and Xiang-Lei Yang.The company is focused on leveraging its broad intellectual property portfolio related to Physiocrines to develop protein therapeutics for the treatment of various rare diseases.